WallStreetZenWallStreetZen

NASDAQ: ROIV
Roivant Sciences Ltd Stock Ownership - Who owns Roivant Sciences?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Roivant Sciences Ltd insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Matthew GlineCEO2024-04-2010,945$10.46
$114.48kSell
Richard PulikCFO2024-04-208,515$10.46
$89.07kSell
Rakhi KumarChief Accounting Officer2024-04-209,881$10.46
$103.36kSell
Eric VenkerPresident COO2024-04-2016,002$10.46
$167.38kSell
Matthew GlineCEO2024-03-30215,991$10.54
$2.28MSell
Mayukh SukhatmePresChief Investment Officer2024-03-30366,211$10.54
$3.86MSell
Richard PulikCFO2024-03-282,341$10.54
$24.67kSell
Eric VenkerPresident COO2024-03-2016,003$10.01
$160.19kSell
Matthew GlineCEO2024-03-2010,945$10.01
$109.56kSell
Rakhi KumarChief Accounting Officer2024-03-201,506$10.01
$15.08kSell

1 of 19

ROIV insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ROIV insiders and whales buy or sell their stock.

ROIV Shareholders

What type of owners hold Roivant Sciences Ltd stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Daniel Allen Gold25.02%201,639,977$2.21BInsider
Qvt Financial LP21.77%175,440,340$1.92BInsider
Qvt Financial LP13.97%112,541,536$1.23BInstitution
Dexcel Pharma Technologies Ltd12.76%102,849,443$1.13BInsider
Keith S. Manchester11.81%95,174,252$1.04BInsider
Svf Investments Uk Ltd9.06%73,031,667$798.97MInsider
Sb Investment Advisers Uk Ltd9.06%73,031,667$798.97MInstitution
Sumitomo Chemical Co Ltd8.84%71,251,083$779.49MInsider
Viking Global Investors LP8.61%69,368,961$758.90MInstitution
Vivek Ramaswamy6.63%53,431,426$584.54MInsider

1 of 3

ROIV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ROIV40.14%59.86%Net SellingNet Selling
ASND100.00%0.00%
LEGN23.61%0.00%
CERE26.94%73.06%Net BuyingNet Selling
TECH97.66%2.34%Net BuyingNet Selling
View Top Biotech Stocks

Roivant Sciences Stock Ownership FAQ

Who owns Roivant Sciences?

Roivant Sciences (NASDAQ: ROIV) is owned by 67.18% institutional shareholders, 100.19% Roivant Sciences insiders, and 0.00% retail investors. Daniel Allen Gold is the largest individual Roivant Sciences shareholder, owning 201.64M shares representing 25.02% of the company. Daniel Allen Gold's Roivant Sciences shares are currently valued at $2.20B.

If you're new to stock investing, here's how to buy Roivant Sciences stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.